Correlation Between Nuvalent and Halozyme Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nuvalent and Halozyme Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Halozyme Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvalent and Halozyme Therapeutics, you can compare the effects of market volatilities on Nuvalent and Halozyme Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Halozyme Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Halozyme Therapeutics.

Diversification Opportunities for Nuvalent and Halozyme Therapeutics

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Nuvalent and Halozyme is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Halozyme Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Halozyme Therapeutics and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Halozyme Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Halozyme Therapeutics has no effect on the direction of Nuvalent i.e., Nuvalent and Halozyme Therapeutics go up and down completely randomly.

Pair Corralation between Nuvalent and Halozyme Therapeutics

Given the investment horizon of 90 days Nuvalent is expected to generate 2.7 times more return on investment than Halozyme Therapeutics. However, Nuvalent is 2.7 times more volatile than Halozyme Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Halozyme Therapeutics is currently generating about 0.34 per unit of risk. If you would invest  7,825  in Nuvalent on November 9, 2024 and sell it today you would earn a total of  845.00  from holding Nuvalent or generate 10.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Nuvalent  vs.  Halozyme Therapeutics

 Performance 
       Timeline  
Nuvalent 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Nuvalent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Halozyme Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Halozyme Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Halozyme Therapeutics is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Nuvalent and Halozyme Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nuvalent and Halozyme Therapeutics

The main advantage of trading using opposite Nuvalent and Halozyme Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Halozyme Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Halozyme Therapeutics will offset losses from the drop in Halozyme Therapeutics' long position.
The idea behind Nuvalent and Halozyme Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities